drugset / Trial / NCT01319682

The Effect of Intravenous Lidocaine on Pain After Lumbar Spinal Fusion

NCT01319682 ↗

Phase 4 Completed 54 enrolled Chung-Ang University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

This prospective randomized study aims to evaluate the effectiveness of intravenous lidocaine injection on the relief of pain in patients undergoing 1-level posterior lumbar fusion. A total of 54 patients will be randomized into one of two groups (group C or group I) based on Excel number generation. Patients in group C will receive received normal saline intravenous injection, and patients in group I will receive an intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous lidocaine infusion of 2 mg/kg/hr. Visual analogue scale pain scores, fentanyl consumption and the frequency at which patients pushed the button (FPB) of a patient-controlled analgesia system will be recorded at 4, 12, 24, 48 hours postoperatively.

Timeline

Start
2011-03
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications

No indication recorded.